-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Tetrodotoxin in Chemotherapy Induced Peripheral Neuropathy
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Tetrodotoxin in Chemotherapy Induced Peripheral Neuropathy report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Tetrodotoxin in Chemotherapy Induced Peripheral Neuropathy Drug Details: Tetrodotoxin (TTX,...
-
Company Insights
Innovation and Patenting activity of WEX Inc Q1 2024
GlobalData, the industry analysis specialist, has released its latest company patent databook "Innovation and Patenting activity of WEX Inc Q1 2024". The databook highlights patenting activity of the company in terms of growth in filings and grants, regions protected, impact of various themes, sector applicability of technologies protected. It provides contextual analysis of technical peers, their strategy, dominance (Grant share) and their recent activities. This is an on-demand databook that will be delivered upon request. The report will be delivered...
-
Product Insights
NewChemotherapy Induced Peripheral Neuropathy – Drugs In Development, 2024
Empower your strategies with our Chemotherapy Induced Peripheral Neuropathy – Drugs In Development, 2024 report and make more profitable business decisions. Chemotherapy-induced peripheral neuropathy (CIPN) is a side effect of cancer treatment. Symptoms include pain, burning, tingling, constipation, muscle weakness, blood pressure changes, and balance problems. Risk factors include longer duration of therapy, pre-existing neuropathy, and type of chemotherapeutic agent. The Chemotherapy Induced Peripheral Neuropathy drugs in development market research report provide comprehensive information on the therapeutics under development for Chemotherapy...
-
Product Insights
NewNeuropathy – Drugs In Development, 2024
Empower your strategies with our Neuropathy – Drugs In Development, 2024 report and make more profitable business decisions. Neuropathy, also known as peripheral neuropathy, refers to a condition involving damage or dysfunction of the nerves outside the brain and spinal cord (peripheral nerves). This condition can affect a single nerve or multiple nerves and can result from various causes. Common types include diabetic neuropathy, resulting from diabetes-related nerve damage due to high blood sugar levels; peripheral neuropathy, often due to conditions...
-
Company Profile
WEX Inc – Company Profile
WEX Inc (WEX) is a technology-based company that offers corporate payment solutions. The company’s fleet solutions portfolio comprises a large fleet, small businesses, government fleets, and over a road card. It provides travel solutions, which consist of virtual travel payment solutions, virtual credit cards, and virtual payment solutions. WEX also offers fleet cards and fuel management, corporate cards, healthcare solutions such as medical claims solutions, employee health accounts, hospital payment solutions, and virtual insurance payment solutions. The company serves commercial...
Add to Basket -
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – Tetrodotoxin
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry Tetrodotoxin Drug Details Tetrodotoxin (TTX, Tectin) is under development for the treatment of cancer...
-
Product Insights
Cancer Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Cancer pain can be defined as a complex sensation that reflects both damages to the body and the body's response to the damage. Pain may arise due to tumor compressing or infiltrating tissue, from treatments and diagnostic procedures, or skin, nerve, and other changes caused by either the body's immune response or hormones released by the tumor. Cancer pain can be treated by analgesic drug therapy, non-opioid analgesics, opioid analgesics, adjuvant drugs, psychotherapy, anesthetic, and neurosurgical pain management. The Cancer...
-
Product Insights
Low Back Pain Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Low Back Pain Drugs in Development Market Report Overview Low back pain can happen anywhere below the ribs and above the legs. Causes of low back pain include overuse, strain, injury, aging, arthritis, illness, and cancer involving the spine. Symptoms include tingling or burning sensation, a dull achy feeling, or sharp pain and weakness in legs or feet. Treatment includes pain medications such as NSAIDs (non-steroidal anti-inflammatory drugs) or opioids and muscle relaxants. Key Mechanism of Actions ·       Prostaglandin G/H...